Oral administration of low molecular weight heparin fractions in rabbits. 1985

C Doutremépuich, and F Toulemonde, and J C Lormeau

A number of studies, including our own, have demonstrated that heparin was not absorbed when administered directly in solution by the oral route. We have attempted to enhance the absorption of orally administered heparin by applying three different approaches: the use of heparin fractions of various molecular weights lower than 6000 D, the complexation of one fraction with glycine (to adjust the ionization of the drug), and the use of gastroresistant capsules administered directly into the stomach. None of these measures resulted in significantly increased absorption, although large doses were administered (15,000 anti-Xa U/kg). New studies will therefore be necessary if heparin and its fractions are to be provided with a satisfactory capacity to be absorbed.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D005170 Factor X Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. Autoprothrombin III,Coagulation Factor X,Stuart Factor,Stuart-Prower Factor,Blood Coagulation Factor X,Factor 10,Factor Ten,Stuart Prower Factor,Factor X, Coagulation
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015951 Factor Xa Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors. Autoprothrombin C,Coagulation Factor Xa,Factor X, Activated,Thrombokinase,Activated Factor X,Blood Coagulation Factor X, Activated,Factor 10A,Factor Ten A,Factor Xa, Coagulation

Related Publications

C Doutremépuich, and F Toulemonde, and J C Lormeau
January 1984, Therapie,
C Doutremépuich, and F Toulemonde, and J C Lormeau
December 2009, Drug development and industrial pharmacy,
C Doutremépuich, and F Toulemonde, and J C Lormeau
June 2010, Thrombosis and haemostasis,
C Doutremépuich, and F Toulemonde, and J C Lormeau
July 2002, Journal of pharmaceutical sciences,
C Doutremépuich, and F Toulemonde, and J C Lormeau
January 2019, American journal of therapeutics,
C Doutremépuich, and F Toulemonde, and J C Lormeau
November 1992, Nederlands tijdschrift voor geneeskunde,
C Doutremépuich, and F Toulemonde, and J C Lormeau
April 1979, British journal of haematology,
C Doutremépuich, and F Toulemonde, and J C Lormeau
January 1987, Haemostasis,
C Doutremépuich, and F Toulemonde, and J C Lormeau
January 1999, Regional anesthesia and pain medicine,
C Doutremépuich, and F Toulemonde, and J C Lormeau
May 1989, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
Copied contents to your clipboard!